Current Trends in Targeted Therapy for Drug-Resistant Infections

Current Trends in Targeted Therapy for Drug-Resistant Infections Publisher Pubmed

Rahbarnia L¹ ; Farajnia S² ; Naghili B¹ ; Ahmadzadeh V² ; Veisi K^{3, 4} ; Baghban R⁵ ; Toraby S⁶

Show Affiliations

1. Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2. Drug Applied Research Center, Tabriz University of Medical Sciences, P.O. Box: 51656-65811, Tabriz, Iran
3. Department of Medical Biotechnology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
4. Biotechnology Department, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6. Immunology Research Center, Tabriz, University of Medical Sciences, Tabriz, Iran

Source: Applied Microbiology and Biotechnology Published:2019

Abstract

Escalating antibiotic resistance is now a serious menace to global public health. It may be led to the emergence of “postantibiotic age” in which most of infections are untreatable. At present, there is an essential need to explore novel therapeutic strategies as a strong and sustainable pipeline to combat antibiotic-resistant infections. This review focuses on recent advances in this area including therapeutic antibodies, antimicrobial peptides, vaccines, gene therapy, genome editing, and phage therapy for tackling drug-resistant infections. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature.

Related Docs

View other Related Docs

1. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria, Microbial Drug Resistance (2018)

2. Enhancing Sirna Cancer Therapy: Multifaceted Strategies With Lipid and Polymer-Based Carrier Systems, International Journal of Pharmaceutics (2024)

3. Mesenchymal Stem Cell-Derived Antimicrobial Peptides As Potential Anti-Neoplastic Agents: New Insight Into Anticancer Mechanisms of Stem Cells and Exosomes, Frontiers in Cell and Developmental Biology (2022)

4. Antimicrobial Peptides: A Promising Strategy for Lung Cancer Drug Discovery?, Expert Opinion on Drug Discovery (2020)

5. Biodegradable Nano-Polymers As Delivery Vehicles for Therapeutic Small Non-Coding Ribonucleic Acids, Journal of Controlled Release (2017)

6. Identification of Antigens From Nosocomial Acinetobacter Baumannii Clinical Isolates in Sera From Icu Staff and Infected Patients Using the Antigenome Technique, World Journal of Microbiology and Biotechnology (2017)

7. An Overview on Display Systems (Phage, Bacterial, and Yeast Display) for Production of Anticancer Antibodies; Advantages and Disadvantages, International Journal of Biological Macromolecules (2022)

8. Global Burden of Bacterial Antimicrobial Resistance 1990–2021: A Systematic Analysis With Forecasts to 2050, The Lancet (2024)

Experts (# of related papers)

View all Related Experts

Fatemeh Atyabi (1)

Ziba Veisi Malekshahi (1)

Style	Citing Format
MLA	Rahbarnia L, et al.. "Current Trends in Targeted Therapy for Drug-Resistant Infections." Applied Microbiology and Biotechnology, vol. 103, no. 20, 2019, pp. 8301-8314.
APA	Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S (2019). Current Trends in Targeted Therapy for Drug-Resistant Infections. Applied Microbiology and Biotechnology, 103(20), 8301-8314.
Chicago	Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S. "Current Trends in Targeted Therapy for Drug-Resistant Infections." Applied Microbiology and Biotechnology 103, no. 20 (2019): 8301-8314.
Harvard	Rahbarnia L et al. (2019) 'Current Trends in Targeted Therapy for Drug-Resistant Infections', Applied Microbiology and Biotechnology, 103(20), pp. 8301-8314.
Vancouver	Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, et al.. Current Trends in Targeted Therapy for Drug-Resistant Infections. Applied Microbiology and Biotechnology. 2019;103(20):8301-8314.
BibTex	@article{ author = {Rahbarnia L and Farajnia S and Naghili B and Ahmadzadeh V and Veisi K and Baghban R and Toraby S}, title = {Current Trends in Targeted Therapy for Drug-Resistant Infections}, journal = {Applied Microbiology and Biotechnology}, volume = {103}, number = {20}, pages = {8301-8314}, year = {2019} }
RIS	TY - JOUR AU - Rahbarnia L AU - Farajnia S AU - Naghili B AU - Ahmadzadeh V AU - Veisi K AU - Baghban R AU - Toraby S TI - Current Trends in Targeted Therapy for Drug-Resistant Infections JO - Applied Microbiology and Biotechnology VL - 103 IS - 20 SP - 8301 EP - 8314 PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract